Author:
Waye Arianna,Chuck Anderson W.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen J, et al. Efficacy, safety and immunigenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187–95.
2. Chuck A, Jacobs P, Nguyen T, Hanrahan A, Loewen J, Mashinter L, et al. Economic analysis of a public program for routine seven valent pneumococcal conjugate vaccine (PCV-7) in infancy, Alberta. Can Commun Dis Rep. 2008;34(10):1–13.
3. Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 10- and 13-valent pnumococcal conjugate vaccines. Vaccine. 2010;28:5484–90.
4. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele D. Changing epidemiology of invasive pneumococcal disease in Canada 1998 to 2007: update from the Calgary Area Streptococcus pneumoniae research (CASPER) study. Can J Infect Dis. 2009;49:205–12.
5. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32–41.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献